201 related articles for article (PubMed ID: 32977589)
1. Molecular Pathogenesis of Pancreatic Ductal Adenocarcinoma: Impact of
Tanaka T; Okada R; Hozaka Y; Wada M; Moriya S; Satake S; Idichi T; Kurahara H; Ohtsuka T; Seki N
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977589
[TBL] [Abstract][Full Text] [Related]
2. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract][Full Text] [Related]
3. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Targets Regulated by Tumor-Suppressive
Mitsueda R; Toda H; Shinden Y; Fukuda K; Yasudome R; Kato M; Kikkawa N; Ohtsuka T; Nakajo A; Seki N
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627217
[TBL] [Abstract][Full Text] [Related]
6. Involvement of anti-tumor
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Yamada Y; Arai T; Kita Y; Kijima Y; Mataki Y; Maemura K; Natsugoe S
Oncotarget; 2018 Jun; 9(48):28849-28865. PubMed ID: 29988949
[TBL] [Abstract][Full Text] [Related]
7. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the
Yonemori K; Seki N; Idichi T; Kurahara H; Osako Y; Koshizuka K; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Oncotarget; 2017 Sep; 8(41):70097-70115. PubMed ID: 29050264
[TBL] [Abstract][Full Text] [Related]
8. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
9. Gene Regulation by Antitumor
Khalid M; Idichi T; Seki N; Wada M; Yamada Y; Fukuhisa H; Toda H; Kita Y; Kawasaki Y; Tanoue K; Kurahara H; Mataki Y; Maemura K; Natsugoe S
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30866526
[TBL] [Abstract][Full Text] [Related]
10. miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A.
Huang X; Jia Y; Shi H; Fan H; Sun L; Zhang H; Wang Y; Chen J; Han J; Wang M; Du J; Zhang J
Asian Biomed (Res Rev News); 2023 Jun; 17(3):124-135. PubMed ID: 37818158
[TBL] [Abstract][Full Text] [Related]
11. Impact of Oncogenic Targets by Tumor-Suppressive
Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
[TBL] [Abstract][Full Text] [Related]
12.
Fukuda K; Seki N; Yasudome R; Mitsueda R; Asai S; Kato M; Idichi T; Kurahara H; Ohtsuka T
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239355
[TBL] [Abstract][Full Text] [Related]
13. Impact of Oncogenic Targets Controlled by Tumor-Suppressive
Nepal P; Hozaka Y; Tanaka T; Wada M; Asai S; Minemura C; Idichi T; Arigami T; Kurahara H; Seki N; Ohtsuka T
Anticancer Res; 2021 Oct; 41(10):4821-4836. PubMed ID: 34593431
[TBL] [Abstract][Full Text] [Related]
14. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Oncogenic Targets by the Tumor-Suppressive
Okada R; Goto Y; Yamada Y; Kato M; Asai S; Moriya S; Ichikawa T; Seki N
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322675
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.
Xin W; Fu Y; Chen L; Ding H; Feng T; Sun J; Qi Y; Hu Y; Fang Q; Fang L
J Gastrointest Oncol; 2023 Apr; 14(2):719-732. PubMed ID: 37201049
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
[TBL] [Abstract][Full Text] [Related]
18. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
19. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
[TBL] [Abstract][Full Text] [Related]
20. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z
Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
